Risperdal, an antipsychotic drug produced by Johnson & Johnson.
Manufacturer: Johnson & Johnson
Risperdal is alleged to increase the levels of prolactin, a hormone that stimulates breast development in young women. Young boys who have taken prolactin and are displaying increased levels of this hormone may develop male breasts, a condition known as gynecomastia. Side effects can include pain in the breast area or nipple discharge.
Further research has supported the allegations that Risperdal causes breast development in young males. A study published in a 2006 issue of the Journal of Clinical Psychopharmacology stated that Risperidone, which is the generic form of Risperdal, “administered to adolescents at doses commonly used for the treatment of psychotic symptoms can strongly increase prolactin levels, with clinical consequences such as gynecomastia.”
The study also indicated that because the long-term effects of Risperdal are not well-documented with particular regard to growth and a delay in puberty, the drug should be prescribed with caution to children and adolescents.
Young boys who have developed breasts as a result of Risperdal can suffer from severe psychological trauma. If you or someone you know have been affected by Risperdal, contact us to begin your Risperdal lawsuit.
Since 1949 we’ve been representing St. Louisans like you. And remember – we work on a contingency fee basis, so you will only be charged a fee if we are successful in recovering compensation for you.